Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Bahn

Showing results (101-110 of 210) with videos related to

Pageof 21
Sort By:
Molecular & Cellular Proteomics : MCP|March 20, 2008
Increased alpha-defensins as a blood marker for schizophrenia susceptibilityRachel M Craddock, Jeffrey T Huang, Edmund Jackson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 28, 2012
Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patientsViktoria Stelzhammer, Paul C Guest, Matthias Rothermundt, et al.
Proteomics. Clinical Applications|March 31, 2015
Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophreniaJulian A Jaros, Hassan Rahmoune, Hendrik Wesseling, et al.
Proteomics|August 24, 2013
Development of a novel assay for proprotein converting enzyme activity on a multiplex bead-based array systemAndreas Albrecht, Hassan Rahmoune, Kristi Leedjärv, et al.
Neuroendocrinology|November 19, 2015
Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical ApproachMan K Chan, Jason D Cooper, Mariska Bot, et al.
Proteomics|May 4, 2011
Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometryDaniel Martins-de-Souza, Paul C Guest, Hannah Steeb, et al.
NPJ Schizophrenia|June 24, 2016
The association between antibodies to neurotropic pathogens and schizophrenia: a case-control studyLot D de Witte, Hans C van Mierlo, Manja Litjens, et al.
Psychopharmacology|June 22, 2016
Molecular serum signature of treatment resistant depressionTillmann Ruland, Man K Chan, Pawel Stocki, et al.
JAMA Psychiatry|April 4, 2019
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic TreatmentJakub Tomasik, Santiago G Lago, Javier Vázquez-Bourgon, et al.
Translational Psychiatry|November 9, 2019
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individualsSung Yeon Sarah Han, Jason D Cooper, Sureyya Ozcan, et al.
Pageof 21

Showing results (101-110 of 210) with videos related to

Sort By:
Pageof 21
Molecular & Cellular Proteomics : MCP|March 20, 2008
Increased alpha-defensins as a blood marker for schizophrenia susceptibilityRachel M Craddock, Jeffrey T Huang, Edmund Jackson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 28, 2012
Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patientsViktoria Stelzhammer, Paul C Guest, Matthias Rothermundt, et al.
Proteomics. Clinical Applications|March 31, 2015
Effects of olanzapine on serum protein phosphorylation patterns in patients with schizophreniaJulian A Jaros, Hassan Rahmoune, Hendrik Wesseling, et al.
Proteomics|August 24, 2013
Development of a novel assay for proprotein converting enzyme activity on a multiplex bead-based array systemAndreas Albrecht, Hassan Rahmoune, Kristi Leedjärv, et al.
Neuroendocrinology|November 19, 2015
Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical ApproachMan K Chan, Jason D Cooper, Mariska Bot, et al.
Proteomics|May 4, 2011
Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometryDaniel Martins-de-Souza, Paul C Guest, Hannah Steeb, et al.
NPJ Schizophrenia|June 24, 2016
The association between antibodies to neurotropic pathogens and schizophrenia: a case-control studyLot D de Witte, Hans C van Mierlo, Manja Litjens, et al.
Psychopharmacology|June 22, 2016
Molecular serum signature of treatment resistant depressionTillmann Ruland, Man K Chan, Pawel Stocki, et al.
JAMA Psychiatry|April 4, 2019
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic TreatmentJakub Tomasik, Santiago G Lago, Javier Vázquez-Bourgon, et al.
Translational Psychiatry|November 9, 2019
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individualsSung Yeon Sarah Han, Jason D Cooper, Sureyya Ozcan, et al.
Pageof 21